Suchergebnisse

145 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: 抗新生物性, antineoplastisch, antineoplastic

• 2016, Shoji H, Motegi M, Osawa K, Okonogi N, Okazaki A, Andou Y, Asao T, Kuwano H, Takahashi T, Ogoshi K
  Output-limiting symptoms induced by radiofrequency hyperthermia. Are they predictable? [tech./dosim.]
  Int J Hyperthermia 32 (2): 199-203
• 2015, Xu L, Guo W, Liu Y, Zhang X, Yu J, Wu W, Zhao T
  [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells] [fremdsprachig]
  Sheng Wu Gong Cheng Xue Bao 31 (9): 1363-1374
• 2015, Sampson JH
  Alternating Electric Fields for the Treatment of Glioblastoma [Kommentar]
  JAMA 314 (23): 2511-2513
• 2015, Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z
  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial [med. Anw.]
  JAMA 314 (23): 2535-2543
• 2015, Tofani S
  [Details] Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment [Review]
  Curr Top Med Chem 15 (6): 572-578
• 2015, Zong C, Ji Y, He Q, Zhu S, Qin F, Tong J, Cao Y
  [Details] Adaptive response in mice exposed to 900 MHz radiofrequency fields: Bleomycin-induced DNA and oxidative damage/repair [med./bio.]
  Int J Radiat Biol 91 (3): 270-276
• 2015, Zhou J, Li X, Liao Y, Feng W, Fu C, Guo X
  Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats [med./bio.]
  Endocrine 49 (1): 258-266
• 2014, Wocik-Piotrowicz K, Kaszuba-Zwoinska J, Rokita E, Thor P, Chrobik P, Nieckarz Z, Michalski J
  [Details] Influence of static and alternating magnetic fields on U937 cell viability [med./bio.]
  Folia Med Cracov 54 (4): 21-33
• 2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
  Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. Anw.]
  Cancer Med 3 (3): 592-602
• 2014, Wen J, Jiang S, Chen Z, Zhao W, Yi Y, Yang R, Chen B
  Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field [med./bio.]
  Int J Nanomedicine 9: 2043-2050
• 2014, Mahna A, Firoozabadi SM, Shankayi Z
  The Effect of ELF Magnetic Field on Tumor Growth after Electrochemotherapy [med. Anw.]
  J Membr Biol 247 (1): 9-15
• 2014, Gellrich D, Becker S, Strieth S
  Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel [med./bio.]
  Cancer Lett 343 (1): 107-114
• 2014, Salwa SP, Bourke MG, Forde PF, O'Shaughnessy M, O'Sullivan ST, Kelly EJ, Soden DM, Clover AJ
  Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management [med. Anw.]
  J Plast Reconstr Aesthet Surg 67 (3): 403-406
• 2013, Butowski N, Wong ET, Mehta MP, Wilson LK
  A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields [Grundlagen]
  Semin Oncol 40 (6): S2-S4
• 2013, Pless M, Droege C, von Moos R, Salzberg M, Betticher D
  A Phase I/II Trial of Tumor Treating Fields (TTFields) Therapy in Combination with Pemetrexed for Advanced Non-Small Cell Lung Cancer [med. Anw.]
  Lung Cancer 81 (3): 445-450
• 2013, Kolmatsui NB, Levitskii EF, Golosova OE, Pyzhova IB
  [The application of UHF therapy for the prevention of complications of specific antiblastoma therapy in the patients presenting with III-IV stage lung cancer] [fremdsprachig]
  Vopr Kurortol Fizioter Lech Fiz Kult (2): 4-7
• 2013, El-Bialy NS, Rageh MM
  Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma [med./bio.]
  Biomed Res Int: 189352
• 2013, Trillo MA, Martinez MA, Cid MA, Ubeda A
  [Details] Retinoic acid inhibits the cytoproliferative response to weak 50Hz magnetic fields in neuroblastoma cells [med./bio.]
  Oncol Rep 29 (3): 885-894
• 2013, Shankayi Z, Firoozabadi SM, Mansurian MG
  The effect of pulsed magnetic field on the molecular uptake and medium conductivity of leukemia cell [med./bio.]
  Cell Biochem Biophys 65 (2): 211-216
• 2012, Cid MA, Ubeda A, Hernandez-Bule ML, Martinez MA, Trillo MA
  [Details] Antagonistic effects of a 50 Hz magnetic field and melatonin in the proliferation and differentiation of hepatocarcinoma cells [med./bio.]
  Cell Physiol Biochem 30 (6): 1502-1516
• 2012, Fonkem E, Wong ET
  NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (8): 895-899
• 2012, Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH
  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality [med. Anw.]
  Eur J Cancer 48 (14): 2192-2202
• 2012, Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y
  The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells [med./bio.]
  PLoS One 7 (9): e46102
• 2012, Miyakoshi Y, Kajihara C, Shimizu H, Yanagisawa H
  [Details] Tempol suppresses micronuclei formation in astrocytes of newborn rats exposed to 50-Hz, 10-mT electromagnetic fields under bleomycin administration [med./bio.]
  Mutat Res Genet Toxicol Environ Mutagen 747 (1): 138-141
• 2012, Raffa V, Riggio C, Smith MW, Jordan KC, Cao W, Cuschieri A
  BNNT-mediated irreversible electroporation: its potential on cancer cells [med./bio.]
  Technol Cancer Res Treat 11 (5): 459-465
• 2012, Sun RG, Chen WF, Qi H, Zhang K, Bu T, Liu Y, Wang SR
  Biologic effects of SMF and paclitaxel on K562 human leukemia cells [med./bio.]
  Gen Physiol Biophys 31 (1): 1-10
• 2012, Golberg A, Rubinsky B
  Towards electroporation based treatment planning considering electric field induced muscle contractions [tech./dosim.]
  Technol Cancer Res Treat 11 (2): 189-201
• 2012, Breton M, Mir LM
  [Details] Microsecond and nanosecond electric pulses in cancer treatments [Review]
  Bioelectromagnetics 33 (2): 106-123
• 2011, Liu Y, Qi H, Sun RG, Chen WF
  An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes [med./bio.]
  Tumori 97 (3): 386-392
• 2011, Rihova B, Etrych T, Sirova M, Tomala J, Ulbrich K, Kovar M
  Synergistic effect of EMF- BEMER- type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma [med. Anw.]
  J Drug Target 19 (10): 890-899
• 2011, Jia D, Rao W, Wang C, Jin C, Wang S, Chen D, Zhang M, Guo J, Chang Z, Liu J
  Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia [med. Anw.]
  Int J Hyperthermia 27 (3): 275-285
• 2011, Hao Q, Wenfang C, Xia A, Qiang W, Ying L, Kun Z, Runguang S
  Effects of a moderate-intensity static magnetic field and adriamycin on K562 cells [med./bio.]
  Bioelectromagnetics 32 (3): 191-199
• 2011, Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ
  The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study [med. Anw.]
  Int J Hyperthermia 27 (1): 27-32
• 2010, Schneiderman RS, Shmueli E, Kirson ED, Palti Y
  TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters [med. Anw.]
  BMC Cancer 10: 229
• 2010, de Campos VE, Teixeira CA, da Veiga VF, Ricci Jr E, Holandino C
  L-tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model [med./bio.]
  Int J Nanomedicine 5: 961-971
• 2010, Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ
  Static magnetic fields enhanced the potency of cisplatin on k562 cells [med./bio.]
  Cancer Biother Radiopharm 25 (4): 401-408
• 2010, Orel VE, Dziatkovs'ka II, Nikolov MO, Romanov AV, Mel'nyk IuH, Dziatkovs'ka NM
  [Effect of doxorubicine and heterogenous electromagnetic and thermal fields on the nonlinear dynamics of carcinoma Guerin development] [fremdsprachig]
  Klin Khir (7): 56-59
• 2010, Gurbuz N, Sirav B, Yuvaci HU, Turhan N, Coskun ZK, Seyhan N
  [Details] Is There Any Possible Genotoxic Effect in Exfoliated Bladder Cells of Rat Under the Exposure of 1800 MHz GSM-Like Modulated Radio Frequency Radiation (RFR)? [med./bio.]
  Electromagn Biol Med 29 (3): 98-104
• 2010, Kaszuba-Zwoinska J, Wojcik K, Bereta M, Ziomber A, Pierzchalski P, Rokita E, Marcinkiewicz J, Zaraska W, Thor P
  [Details] Pulsating electromagnetic field stimulation prevents cell death of puromycin treated U937 cell line [med./bio.]
  J Physiol Pharmacol 61 (2): 201-205
• 2010, Huilgol NG, Gupta S, Dixit R
  Chemoradiation with hyperthermia in the treatment of head and neck cancer [med. Anw.]
  Int J Hyperthermia 26 (1): 21-25
• 2010, Zhijian C, Xiaoxue L, Yezhen L, Shijie C, Lifen J, Jianlin L, Deqiang L, Jiliang H
  [Details] Impact of 1.8-GHz radiofrequency radiation (RFR) on DNA damage and repair induced by doxorubicin in human B-cell lymphoblastoid cells [med./bio.]
  Mutat Res Genet Toxicol Environ Mutagen 695 (1-2): 16-21
• 2009, Nomikou N, McHale AP
  Electrokinetic dispersion of a cancer chemotherapeutic drug for the treatment of solid tumours [tech./dosim.]
  Cancer Lett 279 (2): 202-208
• 2008, Ruiz-Gomez MJ, Merino-Moyano MD, Cebrian-Martin MG, Prieto-Barcia MI, Martinez-Morillo M
  [Details] No effect of 50 Hz 2.45 mT magnetic field on the potency of cisplatin, mitomycin C, and methotrexate in S. cerevisiae [med./bio.]
  Electromagn Biol Med 27 (3): 289-297
• 2008, Xenos T
  Anticancer effects on leiomyosarcoma-bearing Wistar rats after electromagnetic radiation of resonant radiofrequencies [Kommentar]
  Hell J Nucl Med 11 (2): 122-123
• 2008, Emmanouilides C
  Anticancer effects on leiomyosarcoma-baring Wistar rats after electromagnetic radiation of resonant radiofrequencies [Kommentar]
  Hell J Nucl Med 11 (2): 122
• 2008, Magras J
  Anticancer effects on leiomyosarcoma-baring Wistar rats after electromagnetic radiation of resonant radiofrequencies [Kommentar]
  Hell J Nucl Med 11 (2): 122
• 2008, Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M
  Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma [med. Anw.]
  Br J Cancer 98 (2): 388-398
• 2008, Girgert R, Gründker C, Emons G, Hanf V
  [Details] Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells [med./bio.]
  Bioelectromagnetics 29 (3): 169-176
• 2007, Rossi E, Corsetti MT, Sukkar S, Poggi C
  Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicity [med. Anw.]
  Electromagn Biol Med 26 (4): 277-281
• 2007, Avdikos A, Karkabounas S, Metsios A, Kostoula O, Havelas K, Binolis J, Verginadis I, Hatziaivazis G, Simos I, Evangelou A
  Anticancer effects on leiomyosarcoma-bearing Wistar rats after electromagnetic radiation of resonant radiofrequencies [med./bio.]
  Hell J Nucl Med 10 (2): 95-101